Recombinant human erythropoietin at high dose is effective for the treatment of the anemia of myelodysplastic syndromes.
Laporte
J P
JP
Service des Maladies du Sang, Hôpital Saint-Antoine, Paris.
Isnard
F
F
Fenaux
P
P
Woler
M
M
Najman
A
A
D000740:Anemia / Q000188:drug therapy*; D001803:Blood Transfusion; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin